BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 35918894)

  • 1. Recent advances in targeted delivery of non-coding RNA-based therapeutics for atherosclerosis.
    Li X; Qi H; Cui W; Wang Z; Fu X; Li T; Ma H; Yang Y; Yu T
    Mol Ther; 2022 Oct; 30(10):3118-3132. PubMed ID: 35918894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery.
    Hueso M; Mallén A; Suñé-Pou M; Aran JM; Suñé-Negre JM; Navarro E
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine Meets microRNA: Current Advances in RNA-Based Nanotherapies for Atherosclerosis.
    Gadde S; Rayner KJ
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):e73-9. PubMed ID: 27559146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies and challenges for non-viral delivery of non-coding RNAs to the heart.
    Vilaça A; de Windt LJ; Fernandes H; Ferreira L
    Trends Mol Med; 2023 Jan; 29(1):70-91. PubMed ID: 36371335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding microRNA drivers in atherosclerosis.
    Vartak T; Kumaresan S; Brennan E
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35758143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases.
    Li Y; Huo C; Pan T; Li L; Jin X; Lin X; Chen J; Zhang J; Guo Z; Xu J; Li X
    Brief Bioinform; 2019 Jan; 20(1):66-76. PubMed ID: 28968629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNAs in cardiovascular cell biology and atherosclerosis.
    Fasolo F; Di Gregoli K; Maegdefessel L; Johnson JL
    Cardiovasc Res; 2019 Oct; 115(12):1732-1756. PubMed ID: 31389987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-coding RNAs regulating mitochondrial function in cardiovascular diseases.
    Ao X; Ding W; Li X; Xu Q; Chen X; Zhou X; Wang J; Liu Y
    J Mol Med (Berl); 2023 May; 101(5):501-526. PubMed ID: 37014377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncoding RNAs and atherosclerosis.
    Aryal B; Rotllan N; Fernández-Hernando C
    Curr Atheroscler Rep; 2014 May; 16(5):407. PubMed ID: 24623179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Advances in Non-coding RNAs Investigation.
    Jan MI; Ali T; Ishtiaq A; Mushtaq I; Murtaza I
    Adv Exp Med Biol; 2020; 1229():385-426. PubMed ID: 32285426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaching Sex Differences in Cardiovascular Non-Coding RNA Research.
    Jusic A; Salgado-Somoza A; Paes AB; Stefanizzi FM; Martínez-Alarcón N; Pinet F; Martelli F; Devaux Y; Robinson EL; Novella S; On Behalf Of The Eu-CardioRNA Cost Action
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-coding RNAs in endometriosis: a narrative review.
    Panir K; Schjenken JE; Robertson SA; Hull ML
    Hum Reprod Update; 2018 Jul; 24(4):497-515. PubMed ID: 29697794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA (Epi)genetics in cardiovascular diseases.
    Elia L; Condorelli G
    J Mol Cell Cardiol; 2015 Dec; 89(Pt A):11-6. PubMed ID: 26205296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal non-coding RNAs: Emerging therapeutic targets in atherosclerosis.
    Alidadi M; Hjazi A; Ahmad I; Mahmoudi R; Sarrafha M; Reza Hosseini-Fard S; Ebrahimzade M
    Biochem Pharmacol; 2023 Jun; 212():115572. PubMed ID: 37127247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Non-Coding RNA of Human Platelet in Cardiovascular Disease.
    Inzulza-Tapia A; Alarcón M
    Curr Med Chem; 2022; 29(19):3420-3444. PubMed ID: 34967288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Non-Coding RNAs in Cardiovascular Diseases.
    Jiapaer Z; Li C; Yang X; Sun L; Chatterjee E; Zhang L; Lei J; Li G
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncoding RNAs in cancer therapy resistance and targeted drug development.
    Wang WT; Han C; Sun YM; Chen TQ; Chen YQ
    J Hematol Oncol; 2019 Jun; 12(1):55. PubMed ID: 31174564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs As Master Regulators of Atherosclerosis: From Pathogenesis to Novel Therapeutic Options.
    Hosen MR; Goody PR; Zietzer A; Nickenig G; Jansen F
    Antioxid Redox Signal; 2020 Sep; 33(9):621-644. PubMed ID: 32408755
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic targeting of non-coding RNAs in cancer.
    Slaby O; Laga R; Sedlacek O
    Biochem J; 2017 Dec; 474(24):4219-4251. PubMed ID: 29242381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of non-coding RNAs in vascular calcification and opportunities as therapeutic targets.
    Ryu J; Ahn Y; Kook H; Kim YK
    Pharmacol Ther; 2021 Feb; 218():107675. PubMed ID: 32910935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.